Suven Life Sciences granted 133,200 stock options to eligible employees under its ESOP 2020 scheme.
The options have an exercise price of ₹55 each and vest over three tranches from May 2027 to May 2029.
This regulatory disclosure was made pursuant to SEBI Listing Regulations and Master Circular requirements.
The grant represents potential equity dilution of 133,200 shares upon full exercise of all options.